Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Shares Issued: 2022-2025

  • Prokidney's Shares Issued rose 58.88% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$530.9 million, marking a year-over-year change of. This contributed to the annual value of $144.3 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Prokidney's Shares Issued is $7.1 million, which was up 236,833.33% from -$3,000 recorded in Q4 2024.
  • Prokidney's 5-year Shares Issued high stood at $7.1 million for Q3 2025, and its period low was -$542.5 million during Q4 2022.
  • Over the past 2 years, Prokidney's median Shares Issued value was $4.5 million (recorded in 2024), while the average stood at $3.9 million.
  • Data for Prokidney's Shares Issued shows a peak YoY surged of 58.88% (in 2025) over the last 5 years.
  • Prokidney's Shares Issued (Quarterly) stood at -$542.5 million in 2022, then reached -$3,000 in 2024, then soared by 58.88% to $7.1 million in 2025.
  • Its Shares Issued was $7.1 million in Q3 2025, compared to -$3,000 in Q4 2024 and $4.5 million in Q3 2024.